Variant report
Variant | esv2546518 |
---|---|
Chromosome Location | chr17:67343775-67349517 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000252352 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376028217 | chr17:67343788-67343789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549388952 | chr17:67343793-67343794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7224786 | chr17:67343799-67343800 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs537810739 | chr17:67343807-67343808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556246380 | chr17:67343808-67343809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376440419 | chr17:67343830-67343831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571359550 | chr17:67343842-67343843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539293156 | chr17:67343860-67343861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs117463276 | chr17:67343861-67343862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573125706 | chr17:67343866-67343867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7208773 | chr17:67343873-67343874 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs180945753 | chr17:67343886-67343887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536408510 | chr17:67343894-67343895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573689043 | chr17:67343902-67343903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554809183 | chr17:67343949-67343950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185487553 | chr17:67343961-67343962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190411914 | chr17:67344004-67344005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs545654307 | chr17:67344060-67344061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560500699 | chr17:67344074-67344075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs543970711 | chr17:67344084-67344085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370517888 | chr17:67344106-67344107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527854499 | chr17:67344115-67344116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373923728 | chr17:67344118-67344119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543560287 | chr17:67344168-67344169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531598038 | chr17:67344177-67344178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373844859 | chr17:67344200-67344201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375935547 | chr17:67344208-67344209 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2441360 | chr17:67344215-67344216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs181792306 | chr17:67344409-67344410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555767898 | chr17:67344420-67344421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369452083 | chr17:67344425-67344426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566564607 | chr17:67344443-67344444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141365980 | chr17:67344447-67344448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200063399 | chr17:67344493-67344494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368841479 | chr17:67344495-67344496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371830267 | chr17:67344496-67344497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148421341 | chr17:67344497-67344498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71144680 | chr17:67344498-67344499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557218 | chr17:67344499-67344500 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376750824 | chr17:67344501-67344502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184119052 | chr17:67344507-67344508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573926784 | chr17:67344513-67344514 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs61126596 | chr17:67344541-67344542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553092 | chr17:67344560-67344561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145095756 | chr17:67344725-67344726 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs113115150 | chr17:67344727-67344728 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs544266306 | chr17:67344792-67344793 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs556182003 | chr17:67344820-67344821 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs577843349 | chr17:67344847-67344848 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs190018285 | chr17:67344872-67344873 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Congenital generalized hypertrichosis terminalis | 19463983 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Gingival hyperplasia | 19463983 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16417655 | CNVD |
Breast cancer | 21045282 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Honadal dysgenesis | 21408189 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:67339400-67355200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr17:67343400-67344800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
3 | chr17:67343400-67346200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
4 | chr17:67344000-67345400 | Enhancers | Fetal Intestine Large | intestine |
5 | chr17:67344800-67345200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr17:67344800-67345200 | Enhancers | Hela-S3 | cervix |
7 | chr17:67345000-67345400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr17:67345200-67346200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
9 | chr17:67345400-67349400 | Weak transcription | Fetal Intestine Large | intestine |
10 | chr17:67346200-67347400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
11 | chr17:67346200-67347400 | Enhancers | Skeletal Muscle Female | skeletal muscle |
12 | chr17:67346800-67347400 | Enhancers | Psoas Muscle | Psoas |
13 | chr17:67347400-67352800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
14 | chr17:67349400-67349600 | Enhancers | Fetal Intestine Small | intestine |
15 | chr17:67349400-67349800 | Enhancers | Fetal Intestine Large | intestine |